Semaglutide is a medication that has been shown to be effective in promoting weight loss in specific patients and in reducing blood sugar levels and the risk of major cardiovascular events such as heart attack or stroke in patients with type 2 diabetes. Semaglutide is a glucagon-like peptide-1 (GLP-1) agonist that works by increasing insulin release, lowering the amount of glucagon released, delay...

Semaglutide is an oral medication that belongs to the GLP-1 (glycoside-dependent peptide-1) receptor agonist class. It has been approved to treat type 2 diabetes and has shown significant efficacy in clinical trials. The following is market information about Semaglutide: Diabetes market: Semaglutide has shown great potential in the treatment of patients with diabetes. According to reports, semaglu...